NCT02473510 - Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season | Biotech Hunter

Enrollment

301

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

InfluenzaHealthy

Interventions

BIOLOGICAL

Trivalent Influenza Vaccine

A single dose of 10\^(7.0 ± 0.5) FFU per strain of trivalent influenza vaccine will be administered as intranasal spray on Day 1.

OTHER

Placebo

A single dose of placebo matched to trivalent influenza vaccine will be administered as intranasal spray on Day 1.

Trial Locations (3)

Research Site, South Miami

Research Site, Stockbridge

Research Site, Portland